KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Theses
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Theses
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Improving the Delivery of Camptothecin through the Blood-Brain Barrier via Modulation of Paracellular Pathway using E-Cadherin Peptide

    Thumbnail
    View/Open
    Tabanor_ku_0099M_13697_DATA_1.pdf (705.9Kb)
    Issue Date
    2014-12-31
    Author
    Tabanor, Kayann
    Publisher
    University of Kansas
    Format
    31 pages
    Type
    Thesis
    Degree Level
    M.S.
    Discipline
    Chemistry
    Rights
    Copyright held by the author.
    Metadata
    Show full item record
    Abstract
    The successful treatments of brain tumors and many other brain disorders have been limited due to the presence of barricade from microvascular endothelium called the blood-brain barrier (BBB). It was estimated that over 98% of newly developed pharmaceutical drugs do not cross the BBB; therefore, it is necessary to develop methods to improve the delivery of drugs to the brain. In this investigation, we evaluated the ability of HAV6 peptide (Ac-SHAVSS-NH2) to improve the paracellular transport of Camptothecin-glutamate (CPT-Glu) across the BBB using an in-situ rat brain perfusion model. CPT-Glu was synthesized through conjugation between an anti-cancer drug camptothecin (CPT) and L-glutamic acid via an ester bond to improve its solubility. A perfusate containing CPT-Glu (10 mg/kg) and 1.0 mM HAV6 peptide was delivered to the brain of anesthetized Sprague Dawley rats using the in-situ brain perfusion technique. Accumulation in the brain was determined through acidic extraction of CPT-Glu and its hydrolyzed product CPT from harvested brain, followed by detection using LC-MS/MS. The extraction and LC-MS/MS detection methods have been successfully developed to detect 0.25 and 17 ng/mL CPT and CPT-Glu respectively. Both CPT-Glu and CPT were successfully detected in the rat brains after in-situ brain perfusion in the absence and presence of HAV6 peptide. Rats perfused with CPT-Glu in combination with HAV6 had higher deposition of drug in the brain compared to CPT-Glu alone. The HAV6 treated rats had 650.85 ng of CPT equivalent delivered per gram of brain (1.30-fold) compared to 498.40 ng/g in control. The results also showed that CPT-Glu conjugate was hydrolyzed to CPT in the brain after delivery. In future studies, HAV6 peptide perfusion time will be extended for receptor saturation to promote effective BBB opening. The concentration of CPT-Glu will be increased to enhance delivery and improve detection in the brain.
    URI
    http://hdl.handle.net/1808/18084
    Collections
    • Chemistry Dissertations and Theses [336]
    • Theses [3828]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps